Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
  • 首页
The 7th Bio Partering APAC 2023

The 7th Bio Partering APAC 2023

Time:March 23th-24th, 20232

AddressHangzhou · China

ThemeAdhere to the Path of Innovation,Set the Sail for Globalization

Bio Partnering APAC Summit is scheduled to be held again in Hangzhou on March 23-24, 2023, with the theme of ' Adhere to the Path of Innovation,Set the Sail for Globalization '. The conference will again bring together many pharmaceutical leaders and industry colleagues to gather in Hangzhou to actively seek more new opportunities for coopera.

Conference Overview

【Event Background】

The 7th Bio Partering APAC 2022

【Event Highlight】

The 7th Bio Partering APAC 2023

Hot Topics / Agenda

>>【Panel Discussion】Differentiated Innovation: New Cooperation Trend of Biomedical Industry under the Global Pandemic

>>【Panel Discussion】Globalization vs. Localization: Big Pharma's External Innovation Strategy Revolution

>>【Panel Discussion】Accelerating Process: A New Commercialization Journey of Global Innovative Drug Companies

>>【Panel Discussion】License-out Explosion: Key Considerations for New Drugs' Globalization

>>【Panel Discussion】Nothing but Fast: Strategy Construction and Commercial Cooperation of Global Synchronous Clinical Trials

>>【Panel Discussion】China vs. Global: Source Innovation and Business Model Exploration

>>【Panel Discussion】'Licensing-in and Self-develop' :the Differentiated Product Pipeline Layout Strategy

>>【Panel Discussion】Rationality Return: Pharmaceutical Investment New Trend in the Capital Winter

>>【Panel Discussion】IPO 2.0 Era: The IPO and Post-IPO Development of Pharmaceutical Companies Simultaneous Development of Global New Drugs

>>'Domestic BD': Collaborative Innovation of Chinese Big Pharma and Biotech Companies

>>Clinical Value-oriented: Construction of Pharmaceutical Internationalization Capability

>>Licensing-In and Licensing-Out: The Transformation and Innovation of Traditional Chinese Big Pharma

>>Global Collaborative Innovation:Antibody Drug Development and Global Commercialization

>>Capital Market Insight: M&A and business cooperation trends of pharmaceutical companies

>>Case:Adagene’s Cross-border Deals

>>Case:Open Innovation: Global Cooperation Exploration of Huadong Medicine

>>Case:Strategic Cooperation: MNC Trasaction Practice Sharing

>>Master Class:Global Licensing and Cooperative Trasaction of Pharmaceutical Companies

Who should attend

The 7th Bio Partering APAC 2022

Outstanding Past Speakers

The 7th Bio Partering APAC 2022

The 7th Bio Partering APAC 2022

The 7th Bio Partering APAC 2022

The 7th Bio Partering APAC 2022

The 7th Bio Partering APAC 2022

Part of Previous Attending Companies

The 7th Bio Partering APAC 2022

The 7th Bio Partering APAC 2022

Event Organizer

The 11th Asia Pharma R&D Leaders 2022

The 7th Bio Partering APAC 2023
Conference Organizer / Co-Organizer

The 11th Asia Pharma R&D Leaders 2022

Guidance / co-sponsor / support
  • 杨建新 首席执行官,执行董事 基石药业
  • Michael Chen BD VP Jiangsu Simcere Pharmaceutical Group
  • Jing HAN CBO Alphamab Oncology
  • Frank Jiang Consulting Services Leader Clarivate Analytics
  • Mai-Jing Liao CEO RedCloud Bio
  • Alex Wu SVP &CCO JW Therapeutics Co., Ltd.
  • Jeffrey Zhang CBO StemiRNA Therapeutics
  • JIANG Fei CIO (Greater China) CMS
  • Hua Jiang Head of Business Development Abbisko Therapeutics
  • 朱凌宇 Chief Business Development Officer SciClone Pharmaceuticals co., LTD
  • Ning Yuan Co-Chief Business Officer Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  • Blake Salisbury Senior Vice President, Business Development Innovent Biologics (Suzhou) Co.,Ltd
  • Kenneth Law Financial Advisory Partner Deloitte
  • Lily Shen Managing Director Morningside Ventures
  • Yin Zheng Partner Trinity Innovation (Beijing) Investment Management...
  • Ankang LI Chief Strategy and Financial Officer Brii Biosciences
  • Wenbing Yu Assistant General Manager Junshi Biosciences
  • Gaobo Zhou Chief Investment Officer Simcere Pharmaceutical
  • Xiangyang Zhu General Manager Shanghai Huaota Biopharmaceutical Co., Ltd
  • Harm-Jan Borgeld Head of Roche Pharma Partnering Asia Roche
  • Guohuang Fan CEO Immunophage Biotech Co., Ltd.
  • Ye HUA Chairman&CEO BioNova Pharmaceuticals Ltd.
  • Dianna Qian Partner Pivotal bioVenture Partners China
  • Bing Yuan Co-Founder, Chairman, CEO OnCusp Therapeutics
  • Amanda Guo BD Manager Innovent Biologics
  • Haoxun Wang Manager, Early Innovation Partnering Johnson & Johnson Innovation
Cooperative Media
Travel & Stay

For inquiries and media cooperation, please contact

Aili Li

Tel: (86 21) 6095 7201

E-mail: aili.li@shine-consultant.com